Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.82 +0.02 (+2.73%)
As of: Oct 2, 2026 · 9:56 AM EDT

Rani Therapeutics Holdings (RANI) Current Deferred Revenue (2020 - 2026)

Updated

Rani Therapeutics Holdings (RANI) posted Current Deferred Revenue of $5.12 million for Q2 2026, down 25.0% from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Current Deferred Revenue (2020 - 2026) Analysis & Trends

At the end of FY2025, Rani Therapeutics Holdings' Current Deferred Revenue came in at $6.83 million.

  • Annual Current Deferred Revenue shows a five-year compound annual growth rate of 20.2% (FY2020 to FY2025).
  • The Q2 2026 figure stands as the lowest quarterly Current Deferred Revenue since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Rani Therapeutics Holdings 147.86 Mn 156.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.12 Mn
Mar 31, 2026 6.83 Mn
Dec 31, 2025 6.83 Mn
Dec 31, 2020 2.72 Mn
API Access

Rani Therapeutics Holdings Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RANI&period=max&api_key=YOUR_API_KEY